These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16337244

  • 1. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
    Kawabe K, Yoshikawa Y, Adachi Y, Sakurai H.
    Life Sci; 2006 May 08; 78(24):2860-6. PubMed ID: 16337244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
    Yasui H, Tamura A, Takino T, Sakurai H.
    J Inorg Biochem; 2002 Jul 25; 91(1):327-38. PubMed ID: 12121792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
    Sakurai H, Fujii K, Watanabe H, Tamura H.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):1095-101. PubMed ID: 7575515
    [Abstract] [Full Text] [Related]

  • 6. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes.
    Adachi Y, Sakurai H.
    Chem Pharm Bull (Tokyo); 2004 Apr 25; 52(4):428-33. PubMed ID: 15056957
    [Abstract] [Full Text] [Related]

  • 7. The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
    Gao L, Niu Y, Liu W, Xie M, Liu X, Chen Z, Li L.
    Clin Chim Acta; 2008 Feb 25; 388(1-2):89-94. PubMed ID: 17991430
    [Abstract] [Full Text] [Related]

  • 8. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P, Vieites M, Torre MH, Costa-Filho AJ, Cerecetto H, González M, Lavaggi ML, Adachi Y, Sakurai H, Gambino D.
    J Inorg Biochem; 2006 Feb 25; 100(2):281-7. PubMed ID: 16386797
    [Abstract] [Full Text] [Related]

  • 9. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M, Wakasugi K, Saito R, Adachi Y, Yoshikawa Y, Sakurai H, Katoh A.
    J Inorg Biochem; 2006 Feb 25; 100(2):260-9. PubMed ID: 16387366
    [Abstract] [Full Text] [Related]

  • 10. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Zuo YQ, Liu WP, Niu YF, Tian CF, Xie MJ, Chen XZ, Li L.
    J Pharm Pharmacol; 2008 Oct 25; 60(10):1335-40. PubMed ID: 18812026
    [Abstract] [Full Text] [Related]

  • 11. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
    Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y.
    Biochem Biophys Res Commun; 2001 Mar 25; 281(5):1190-3. PubMed ID: 11243860
    [Abstract] [Full Text] [Related]

  • 12. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.
    Pereira MJ, Carvalho E, Eriksson JW, Crans DC, Aureliano M.
    J Inorg Biochem; 2009 Dec 25; 103(12):1687-92. PubMed ID: 19850351
    [Abstract] [Full Text] [Related]

  • 13. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y, Yoshida J, Kodera Y, Katoh A, Takada J, Sakurai H.
    J Med Chem; 2006 Jun 01; 49(11):3251-6. PubMed ID: 16722643
    [Abstract] [Full Text] [Related]

  • 14. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
    Takino T, Yasui H, Yoshitake A, Hamajima Y, Matsushita R, Takada J, Sakurai H.
    J Biol Inorg Chem; 2001 Feb 01; 6(2):133-42. PubMed ID: 11293406
    [Abstract] [Full Text] [Related]

  • 15. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
    Sakurai H, Sano H, Takino T, Yasui H.
    J Inorg Biochem; 2000 May 30; 80(1-2):99-105. PubMed ID: 10885469
    [Abstract] [Full Text] [Related]

  • 16. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
    Yoshikawa Y, Ueda E, Kawabe K, Miyake H, Takino T, Sakurai H, Kojima Y.
    J Biol Inorg Chem; 2002 Jan 30; 7(1-2):68-73. PubMed ID: 11862542
    [Abstract] [Full Text] [Related]

  • 17. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
    Li YR, Gao LH, Ma YL, Niu YF, Liu WP, Li L.
    Yao Xue Xue Bao; 2008 Mar 30; 43(3):318-22. PubMed ID: 18630272
    [Abstract] [Full Text] [Related]

  • 18. The pharmacology of the insulinomimetic effect of zinc complexes.
    Sakurai H, Adachi Y.
    Biometals; 2005 Aug 30; 18(4):319-23. PubMed ID: 16158223
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
    Katoh A, Matsumura Y, Yoshikawa Y, Yasui H, Sakurai H.
    J Inorg Biochem; 2009 Apr 30; 103(4):567-74. PubMed ID: 19162327
    [Abstract] [Full Text] [Related]

  • 20. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD, Thompson KH, Hanson GR, Lam E, Aebischer N, Orvig C.
    J Am Chem Soc; 2005 Apr 13; 127(14):5104-15. PubMed ID: 15810845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.